21 Jul Borderless COVID-19, Restricted Vaccines: The Complex Challenge of Vaccine Equity during the Coronavirus Pandemic
More than a year and a half after the beginning of the SARS-CoV-2 pandemic, the world still faces various social and economic challenges. One of them is inequitable access to COVID-19 vaccines doses, especially in Low- and Middle-Income Countries.
In early June ended the Seventy-fourth World Health Assembly (WHA) with the theme: ‘Ending this pandemic, preventing the next’. The World Health Organization (WHO) could not have been clearer regarding its goals and guidelines for this Assembly, focusing on the principle that ‘‘No one is safe until everyone is safe’’. Initiatives established by the WHO such as the ACT-Accelerator were the first steps of trying to tackle the pandemic, but they need to be borne by international actors – especially country governments – to be efficient.
Borderless COVID-19, Restricted Vaccines: The Complex Challenge of Vaccine Equity during the Coronavirus Pandemic is thus an attempt to outline the key role and projects of the WHO regarding vaccine equity during the coronavirus pandemic. It also aims to comprehend how equitable access to health care became a worldwide priority and how it may shape the way in which international actors will handle future health emergencies and organize our healthcare system.
About the Author
Marion Fauveau joined the IHF team as an intern in April 2021. She just graduated with her Bachelor’s degree in Applied Foreign Languages at the University of Nanterre (France). As part of her internship at the IHF, she produced several reports regarding COVID-19 vaccine equity, the World Health Assembly and the World Health Organization’s webinars.